(Total Views: 700)
Posted On: 12/31/2020 12:06:13 AM
Post# of 151807
FDA Accepts Protocol for Adding an Open-Label Extension to CytoDyn’s Phase 3 Trial for Severe-to-Critical COVID-19 Patients
https://www.cytodyn.com/newsroom/press-releas...tension-to
https://www.cytodyn.com/newsroom/press-releas...tension-to
(5)
(0)Scroll down for more posts ▼
